A long-term ketogenic diet causes hyperlipidemia, liver dysfunction, and glucose intolerance from impaired insulin secretion in mice
Science Advances · 19.09.2025 · 11 (38)
DOI: 10.1126/sciadv.adx2752 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 19.09.2025. Verfasst von Molly R Gallop und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT, USA. Hauptthemen laut MEDLINE: Diet, Ketogenic, Glucose Intolerance, Hyperlipidemias, Insulin Secretion. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Ketogenic diets (KDs)—very-low-carbohydrate and very-high-fat diets—have gained popularity as therapeutic against obesity and type 2 diabetes. However, their long-term effects on metabolic health remain understudied. Here, we show that, in male and female mice, a KD protects against weight gain and induces weight loss but over time leads to the development of hyperlipidemia, hepatic steatosis, and severe glucose intolerance. Unlike mice on conventional high-fat diet, KD-fed mice remain insulin sensitive and display low-insulin levels. Hyperglycemic clamp and ex vivo glucose-stimulated insulin secretion assays revealed systemic and cell-intrinsic impairments in insulin secretion. Transcriptomic profiling of islets from KD-fed mice indicated endoplasmic reticulum (ER)/Golgi stress and disrupted ER-Golgi protein trafficking, which were confirmed by electron microscopy showing a dilated Golgi network consistent with defective insulin granule trafficking and secretion. Together, these results suggest that long-term KD leads to multiple aberrations of metabolic parameters that caution their systematic use as a health-promoting dietary intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT, USA.
- Utah Diabetes and Metabolism Research Center, Salt Lake City, UT, USA.
- Electron Microscopy, Health Science Center Cores, The University of Utah, Salt Lake City, UT, USA.
- Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA.
- Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
ORCID-Profile: Molly R Gallop, Elijah T Matsuzaki, Willisa Liou, Faith E Smart, Seth Roberts, Kimberley J Evason, Amandine Chaix
Förderung
- NIDDK NIH HHS
- NIA NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Gallop, M. R., Vieira, R. F. L., Mower, P. D., Matsuzaki, E. T., Liou, W., Smart, F. E., Roberts, S., Evason, K. J., Holland, W. L., & Chaix, A. (2025). A long-term ketogenic diet causes hyperlipidemia, liver dysfunction, and glucose intolerance from impaired insulin secretion in mice. Science Advances, 11(38). https://doi.org/10.1126/sciadv.adx2752
Vancouver
Gallop MR, Vieira RFL, Mower PD, Matsuzaki ET, Liou W, Smart FE, et al. A long-term ketogenic diet causes hyperlipidemia, liver dysfunction, and glucose intolerance from impaired insulin secretion in mice. Science Advances. 2025;11(38). doi:10.1126/sciadv.adx2752
BibTeX
@article{Gallop2025,
author = {Gallop, Molly R and Vieira, Renan F L and Mower, Peyton D and Matsuzaki, Elijah T and Liou, Willisa and Smart, Faith E and Roberts, Seth and Evason, Kimberley J and Holland, William L and Chaix, Amandine},
title = {A long-term ketogenic diet causes hyperlipidemia, liver dysfunction, and glucose intolerance from impaired insulin secretion in mice},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {38},
doi = {10.1126/sciadv.adx2752}
}
EUVIMED